指南与共识头颈外科

头颈癌临床实践指南中系统评价的分析

Analysis of Systematic Reviews in Clinical Practice Guidelines for Head and Neck Cancer.
指南 / 共识 · Laryngoscope · 2022-02-14

该研究采用回顾性横断面分析,检索2017年1月至2021年5月发表的16部头颈癌临床实践指南及其引用的142篇系统评价,用AMSTAR-2和PRISMA工具评估报告质量。PRISMA完成度均值76.41%(SD=16.9),AMSTAR-2完成度均值67.55%(SD=20.9),最低评分条目包括资金来源和发表偏倚,Cochrane系统评价评分较高但仅占2.11%(3/142)。

要点

  • 16部指南引用的142篇系统评价中,AMSTAR-2完成度均值67.55%(SD=20.9)。
  • PRISMA完成度均值76.41%(SD=16.9),各指南间范围67.15%至87.65%。
  • 资金来源和发表偏倚是AMSTAR-2评分最低的条目。

核心结论

  • 头颈癌临床实践指南引用的系统评价对AMSTAR-2和PRISMA条目的依从性存在差异,作为支持证据的系统评价报告质量有待提高。

研究设计与样本

  • 回顾性横断面分析,通过PubMed检索2017年1月至2021年5月发表的与头颈癌管理相关的临床实践指南并分析其引用的所有系统评价。
  • 共纳入16部临床实践指南和142篇独特的系统评价,采用AMSTAR-2和PRISMA工具评估,研究特征以盲法三重方式提取。

主要发现

  • 各指南间PRISMA完成度范围为67.15%至87.65%,均值76.41%(SD=16.9)。
  • 各指南间AMSTAR-2完成度范围为34.38%至84.38%,所有系统评价均值67.55%(SD=20.9)。
  • AMSTAR-2评分最低的条目包括资金来源和发表偏倚。
  • 由Cochrane小组完成的系统评价获得更高评分,但仅占指南引用全部系统评价的2.11%(3/142)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Clinical practice guidelines (CPGs) are essential to clinical decision-making as their recommendations are supported by published literature. Systematic reviews are considered the highest quality of evidence used to underpin these guidelines. However, research to support these recommendations may lack compliance to quality reporting among systematic reviews (SRs). Here, we aim to evaluate the quality of SRs underpinning CPG recommendations for the management of head and neck cancer (HNC). STUDY DESIGN: Retrospective cross-sectional analysis. METHODS: Using PubMed, we searched for CPGs pertinent to the management of head and neck cancer published between January 2017 and May 2021. Relevant guidelines were analyzed for all SRs. Cited SRs in CPGs were evaluated using A Measurement Tool to Assess Systematic Reviews-2 (AMSTAR-2) and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) instruments. Study characteristics were extracted in a masked triplicate fashion. RESULTS: A total of 16 CPGs and 142 unique SRs were included in our study. PRISMA completion ranged from 67.15% to 87.65% across CPGs with a mean of 76.41% (SD = 16.9). AMSTAR-2 completion ranged from 34.38% to 84.38% across CPGs with a mean of 67.55% (SD = 20.9) among all SRs. The lowest rated items included funding sources and publication bias. A higher score was achieved in SR done by Cochrane group and it was only 2.11% (3/142) of all SR's quoted in CPG. CONCLUSION: Adherence to AMSTAR-2 and PRISMA items exhibits a variation among SRs cited in CPGs for the management of HNC. The mature underpinning CPG recommendation of SRs cited as supportive evidence could be enhanced in reporting quality. LEVEL OF EVIDENCE: NA Laryngoscope, 132:1976-1983, 2022.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Dhillon J, Khan T, Siddiqui B, et al. Analysis of Systematic Reviews in Clinical Practice Guidelines for Head and Neck Cancer. Laryngoscope. 2022. PMID: 35156725. doi:10.1002/lary.30051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。